January 1, 2024 · Form 4 insider transaction
Joyce Roby bought 12,668 shares of bioAffinity Technologies, Inc. at $1.48 per share, a transaction worth $18.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 23 days after the transaction.
Represents a grant from the Issuer to Dr. Joyce of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.